Raman Spectroscopic Analysis of Molecular Structure and Mechanical Properties of Hypophosphatasia Primary Tooth
Molecules · 22.12.2024 · 29 (24) · 6049
DOI: 10.3390/molecules29246049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 22.12.2024. Verfasst von Hayata Imamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ceramic Physics Laboratory, Kyoto Institute of Technology, Sakyo-ku, Matsugasaki, Kyoto 606-8585, Japan. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Hypophosphatasia, Tooth, Deciduous, Biomechanical Phenomena. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST SPRING, Kyoto Prefectural Public University Corporation joint research.
Abstract (Originalsprache)
Mild hypophosphatasia (HPP) can be difficult to distinguish from other bone disorders in the absence of typical symptoms such as the premature loss of primary teeth. Therefore, this study aimed to analyze the crystallinity of hydroxyapatite (HAp) and the three-dimensional structure of collagen in HPP teeth at the molecular level and to search for new biomarkers of HPP. Raman spectroscopy was used to investigate the molecular structure, composition, and mechanical properties of primary teeth from healthy individuals and patients with HPP. The results showed that the crystallinity of HAp decreased and the carbonate apatite content increased in the region near the dentin–enamel junction (DEJ) of HPP primary teeth. X-ray diffraction (XRD) analyses confirmed a decrease in HAp crystallinity near the DEJ, and micro-computed tomography (CT) scanning revealed a decrease in mineral density in this region. These results suggest incomplete calcification in HPP primary dentin and may contribute to the development of diagnostic and therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ceramic Physics Laboratory, Kyoto Institute of Technology, Sakyo-ku, Matsugasaki, Kyoto 606-8585, Japan.
- Department of Dental Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.
- Department of Dentistry, Kyoto Prefectural Rehabilitation Hospital for Mentally and Physically Disabled, Naka Ashihara, Joyo 610-0113, Japan.
- Department of Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, 465 Kajii-cho, Kyoto 602-8566, Japan.
- Department of Biomolecular Chemistry, Faculty of Science and Technology, Kyoto Prefectural University, 1-5, Shimogamo-nakaragi, Sakyo-ku, Kyoto 606-8522, Japan.
- Department of Pharmacology, Tokyo Dental College, 2-9-18 Kandamisaki-cho, Chiyoda-ku, Tokyo 101-0061, Japan.
ORCID-Profile: Hayata Imamura, Tetsuya Adachi, Wenliang Zhu, Toshiro Yamamoto, Hiroaki Onoda
Förderung
- JST SPRING
- Kyoto Prefectural Public University Corporation joint research
Zitieren
APA
Imamura, H., Adachi, T., Zhu, W., Yamamoto, T., Kanamura, N., Onoda, H., Nakamura-Takahashi, A., Kasahara, M., Nakada, M., Sato, H., & Pezzotti, G. (2024). Raman Spectroscopic Analysis of Molecular Structure and Mechanical Properties of Hypophosphatasia Primary Tooth. Molecules, 29(24), 6049. https://doi.org/10.3390/molecules29246049
Vancouver
Imamura H, Adachi T, Zhu W, Yamamoto T, Kanamura N, Onoda H, et al. Raman Spectroscopic Analysis of Molecular Structure and Mechanical Properties of Hypophosphatasia Primary Tooth. Molecules. 2024;29(24):6049. doi:10.3390/molecules29246049
BibTeX
@article{Imamura2024,
author = {Imamura, Hayata and Adachi, Tetsuya and Zhu, Wenliang and Yamamoto, Toshiro and Kanamura, Narisato and Onoda, Hiroaki and Nakamura-Takahashi, Aki and Kasahara, Masataka and Nakada, Masaru and Sato, Hideo and Pezzotti, Giuseppe},
title = {Raman Spectroscopic Analysis of Molecular Structure and Mechanical Properties of Hypophosphatasia Primary Tooth},
journal = {Molecules},
year = {2024},
volume = {29},
number = {24},
pages = {6049},
doi = {10.3390/molecules29246049}
}
EUVIMED